4th Circuit Reverses $1.25M Pradaxa Verdict: No New Evidence To Escape Preemption

Mealey's (January 11, 2021, 2:57 PM EST) -- RICHMOND, Va. — The Fourth Circuit U.S. Court of Appeals on Jan. 6 vacated a $1.25 million Pradaxa fraud verdict after finding there was no newly discovered information about risks from  the prescription anticoagulant, thus making the claim preempted by federal law....